1. Home
  2. TBPH vs YRD Comparison

TBPH vs YRD Comparison

Compare TBPH & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • YRD
  • Stock Information
  • Founded
  • TBPH 2013
  • YRD 2012
  • Country
  • TBPH United States
  • YRD China
  • Employees
  • TBPH N/A
  • YRD N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • YRD Finance: Consumer Services
  • Sector
  • TBPH Health Care
  • YRD Finance
  • Exchange
  • TBPH Nasdaq
  • YRD Nasdaq
  • Market Cap
  • TBPH 464.5M
  • YRD 411.2M
  • IPO Year
  • TBPH N/A
  • YRD 2015
  • Fundamental
  • Price
  • TBPH $9.01
  • YRD $7.38
  • Analyst Decision
  • TBPH Buy
  • YRD
  • Analyst Count
  • TBPH 4
  • YRD 0
  • Target Price
  • TBPH $13.75
  • YRD N/A
  • AVG Volume (30 Days)
  • TBPH 192.5K
  • YRD 209.0K
  • Earning Date
  • TBPH 05-12-2025
  • YRD 03-20-2025
  • Dividend Yield
  • TBPH N/A
  • YRD 5.29%
  • EPS Growth
  • TBPH N/A
  • YRD N/A
  • EPS
  • TBPH N/A
  • YRD 2.48
  • Revenue
  • TBPH $64,381,000.00
  • YRD $795,426,969.00
  • Revenue This Year
  • TBPH $51.09
  • YRD N/A
  • Revenue Next Year
  • TBPH N/A
  • YRD N/A
  • P/E Ratio
  • TBPH N/A
  • YRD $2.91
  • Revenue Growth
  • TBPH 12.12
  • YRD 18.59
  • 52 Week Low
  • TBPH $7.44
  • YRD $4.12
  • 52 Week High
  • TBPH $10.90
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 41.82
  • YRD 54.51
  • Support Level
  • TBPH $8.72
  • YRD $6.54
  • Resistance Level
  • TBPH $9.55
  • YRD $7.65
  • Average True Range (ATR)
  • TBPH 0.25
  • YRD 0.55
  • MACD
  • TBPH -0.04
  • YRD -0.04
  • Stochastic Oscillator
  • TBPH 34.94
  • YRD 43.60

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: